Redmile Group, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Redmile Group, LLC

$1.53 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $6.72 Million - $8.59 Million	495,103 Added 10.31%	5,296,643 $83.3 Million
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $778,732 - $1.27 Million	-77,026 Reduced 1.58%	4,801,540 $77.4 Million
Q2 2023 Aug 14, 2023	SELL	$13.28 - $15.96 $9.34 Million - $11.2 Million	-703,539 Reduced 12.6%	4,878,566 $68.7 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $28.4 Million - $44 Million	1,988,788 Added 55.35%	5,582,105 $86.2 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $9.21 Million - $11.8 Million	620,288 Added 20.86%	3,593,317 $58.9 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $19.1 Million - $31.2 Million	1,542,112 Added 107.77%	2,973,029 $55 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $6.98 Million - $10.7 Million	766,100 Added 115.23%	1,430,917 $18.8 Million
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $25.9 Million - $125 Million	-3,366,704 Reduced 83.51%	664,817 $6.5 Million
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $5.64 Million - $7.92 Million	-213,200 Reduced 5.02%	4,031,521 $137 Million
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $3.5 Million - $5.13 Million	-106,923 Reduced 2.46%	4,244,721 $155 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $3.49 Million - $4.9 Million	-86,324 Reduced 1.95%	4,351,644 $195 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $17.4 Million - $22.3 Million	-336,950 Reduced 7.06%	4,437,968 $253 Million
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $8.94 Million - $11.9 Million	-204,023 Reduced 4.1%	4,774,918 $245 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $5.09 Million - $8.93 Million	-137,322 Reduced 2.68%	4,978,941 $297 Million
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $13.7 Million - $28.2 Million	406,765 Added 8.64%	5,116,263 $211 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $2.26 Million - $4.99 Million	-71,400 Reduced 1.49%	4,709,498 $293 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $51 Million - $99.4 Million	2,557,522 Added 115.03%	4,780,898 $162 Million
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $12.5 Million - $15.6 Million	594,723 Added 36.52%	2,223,376 $50.1 Million
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $506,482 - $724,772	-24,527 Reduced 1.48%	1,628,653 $37.8 Million
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $3.37 Million - $6.38 Million	176,600 Added 11.96%	1,653,180 $34.7 Million
Q3 2018 Nov 14, 2018	SELL	$33.57 - $42.1 $16,785 - $21,050	-500 Reduced 0.03%	1,476,580 $57.2 Million
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $13.2 Million - $29.5 Million	655,800 Added 79.85%	1,477,080 $58.1 Million
Q1 2018 May 15, 2018	BUY	$20.04 - $29.71 $2.75 Million - $4.08 Million	137,400 Added 20.09%	821,280 $0
Q4 2017 Feb 14, 2018	SELL	$16.54 - $24.2 $645,060 - $943,800	-39,000 Reduced 5.4%	683,880 $14.7 Million
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $12.8 Million - $13.7 Million	722,880	722,880 $12 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

343K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account